| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2021 ( Subtotal = $0 ) |
| 2021 | 2018 | AM BIOTECHNOLOGIES, LLC | 12521 GULF FWY | HOUSTON | TX | 77034-4509 | HARRIS | USA | R43GM126604 | Unified Process for the Discovery of Protein Biomarkers and their X-Aptamer Affinity Reagents | 001 | 1 | NIH | 7/3/2021 | $0 |
|
 | Issue Date FY: 2020 ( Subtotal = -$118,662 ) |
| 2020 | 2019 | AM BIOTECHNOLOGIES, LLC | 12521 GULF FWY | HOUSTON | TX | 77034-4509 | HARRIS | USA | R43GM126604 | Unified Process for the Discovery of Protein Biomarkers and their X-Aptamer Affinity Reagents | 001 | 2 | NIH | 2/28/2020 | -$118,662 |
| 2020 | 2019 | AM BIOTECHNOLOGIES, LLC | 12521 GULF FWY | HOUSTON | TX | 77034-4509 | HARRIS | USA | R43GM126604 | Unified Process for the Discovery of Protein Biomarkers and their X-Aptamer Affinity Reagents | 000 | 2 | NIH | 12/31/2019 | $0 |
|
 | Issue Date FY: 2019 ( Subtotal = $118,662 ) |
| 2019 | 2019 | AM BIOTECHNOLOGIES, LLC | 12521 GULF FWY | HOUSTON | TX | 77034-4509 | HARRIS | USA | R43GM126604 | Unified Process for the Discovery of Protein Biomarkers and their X-Aptamer Affinity Reagents | 001 | 2 | NIH | 8/19/2019 | $118,662 |
| 2019 | 2018 | AM BIOTECHNOLOGIES, LLC | 12521 GULF FWY | HOUSTON | TX | 77034-4509 | HARRIS | USA | R43GM126604 | Unified Process for the Discovery of Protein Biomarkers and their X-Aptamer Affinity Reagents | 000 | 1 | NIH | 4/2/2019 | $0 |
| 2019 | 2016 | AM BIOTECHNOLOGIES, LLC | 12521 GULF FWY | HOUSTON | TX | 77034-4509 | HARRIS | USA | R44GM108110 | X-Aptamer Selection Kit | 000 | 4 | NIH | 12/14/2018 | $0 |
|
 | Issue Date FY: 2018 ( Subtotal = $185,564 ) |
| 2018 | 2018 | AM BIOTECHNOLOGIES, LLC | 12521 GULF FWY | HOUSTON | TX | 77034-4509 | HARRIS | USA | R43GM126604 | Unified Process for the Discovery of Protein Biomarkers and their X-Aptamer Affinity Reagents | 000 | 1 | NIH | 5/11/2018 | $185,564 |
|
 | Issue Date FY: 2017 ( Subtotal = $0 ) |
| 2017 | 2014 | AM BIOTECHNOLOGIES, LLC | 12521 GULF FWY | HOUSTON | TX | 77034-4509 | HARRIS | USA | R44GM086937 | New Reagents for RNA-based Therapeutic Technologies | 000 | 3 | NIH | 1/10/2017 | $0 |
|
 | Issue Date FY: 2016 ( Subtotal = $559,001 ) |
| 2016 | 2016 | A M BIOTECHNOLOGIES LLC | 1700 The Strand | Galveston | TX | 77555-0001 | GALVESTON | USA | R44GM108110 | X-Aptamer Selection Kit | 000 | 4 | NIH | 8/16/2016 | $559,001 |
|
 | Issue Date FY: 2015 ( Subtotal = $700,620 ) |
| 2015 | 2015 | A M BIOTECHNOLOGIES LLC | 1700 The Strand | Galveston | TX | 77555-0001 | GALVESTON | USA | R44GM108110 | X-Aptamer Selection Kit | 000 | 3 | NIH | 8/25/2015 | $700,620 |
|
 | Issue Date FY: 2014 ( Subtotal = $896,547 ) |
| 2014 | 2014 | A M BIOTECHNOLOGIES LLC | 1700 The Strand | Galveston | TX | 77555-0001 | GALVESTON | USA | R44GM086937 | New Reagents for RNA-based Therapeutic Technologies | 000 | 3 | NIH | 8/26/2014 | $477,211 |
| 2014 | 2014 | A M BIOTECHNOLOGIES LLC | 1700 The Strand | Galveston | TX | 77555-0001 | GALVESTON | USA | R43GM108110 | X-Aptamer Selection Kit | 001 | 2 | NIH | 8/28/2014 | $200,000 |
| 2014 | 2014 | A M BIOTECHNOLOGIES LLC | 1700 The Strand | Galveston | TX | 77555-0001 | GALVESTON | USA | R43GM108110 | X-Aptamer Selection Kit | 000 | 2 | NIH | 8/27/2014 | $219,336 |
|
 | Issue Date FY: 2013 ( Subtotal = $749,846 ) |
| 2013 | 2013 | A M BIOTECHNOLOGIES LLC | 1700 The Strand | Galveston | TX | 77555-0001 | GALVESTON | USA | R44GM086937 | New Reagents for RNA-based Therapeutic Technologies | 000 | 2 | NIH | 9/18/2013 | $519,358 |
| 2013 | 2013 | A M BIOTECHNOLOGIES LLC | 1700 The Strand | Galveston | TX | 77555-0001 | GALVESTON | USA | R43GM108110 | X-Aptamer Selection Kit | 000 | 1 | NIH | 8/22/2013 | $230,488 |
|
 | Issue Date FY: 2012 ( Subtotal = $180,115 ) |
| 2012 | 2012 | A M BIOTECHNOLOGIES LLC | 1700 The Strand | Galveston | TX | 77555-0001 | GALVESTON | USA | R43GM100777 | NEW BUILDING BLOCKS FOR THE SYNTHESIS OF MODIFIED RNAS | 000 | 1 | NIH | 3/1/2012 | $180,115 |
|
 | Issue Date FY: 2011 ( Subtotal = $631,939 ) |
| 2011 | 2011 | A M BIOTECHNOLOGIES LLC | 1700 The Strand | Galveston | TX | 77555-0001 | GALVESTON | USA | R43GM086937 | NEW REAGENTS FOR THE SYNTHESIS OF PHOSPHORODITHIOATE-MODIFIED 2'-O-METHYL RNAS | 000 | 1 | NIH | 6/28/2011 | $156,729 |
| 2011 | 2011 | A M BIOTECHNOLOGIES LLC | 1700 The Strand | Galveston | TX | 77555-0001 | GALVESTON | USA | R44GM084552 | NEW REAGENTS FOR SYNTHESIS OF HIGH POTENCY SIRNA | 000 | 4 | NIH | 8/25/2011 | $475,210 |
|
 | Issue Date FY: 2010 ( Subtotal = $474,025 ) |
| 2010 | 2010 | A M BIOTECHNOLOGIES LLC | 1700 The Strand | Galveston | TX | 77555-0001 | GALVESTON | USA | R44GM084552 | NEW REAGENTS FOR SYNTHESIS OF HIGH POTENCY SIRNA | 000 | 3 | NIH | 8/27/2010 | $474,025 |
|
 | Issue Date FY: 2009 ( Subtotal = $223,207 ) |
| 2009 | 2009 | A M BIOTECHNOLOGIES LLC | 1700 The Strand | Galveston | TX | 77555-0001 | GALVESTON | USA | R43CA141842 | OPTIMIZE RNA-APTAMER FOR BIOMARKER MOLECULE CD30 | 000 | 1 | NIH | 6/23/2009 | $123,605 |
| 2009 | 2009 | A M BIOTECHNOLOGIES LLC | 1700 The Strand | Galveston | TX | 77555-0001 | GALVESTON | USA | R43GM084552 | NEW REAGENTS FOR SYNTHESIZING NUCLEASE-RESISTANT SIRNA | 000 | 2 | NIH | 6/25/2009 | $99,602 |
|
 | Issue Date FY: 2008 ( Subtotal = $99,600 ) |
| 2008 | 2008 | A M BIOTECHNOLOGIES LLC | 6023 AVENUE SOUTH | GALVESTON | TX | 77551 | GALVESTON | USA | R43GM084552 | NEW REAGENTS FOR SYNTHESIZING NUCLEASE-RESISTANT SIRNA | 000 | 1 | NIH | 6/26/2008 | $99,600 |
|
|